i was just rereading some posts here when i came across this one that is high by nearly 50% It amazes me when people make all sorts of assumptions (usually wrong) When accurate data is available. Using SAR https://wcsecure.weblink.com.au/pdf/LYC/02636506.pdf pg. 16 financial income for first 6 months is AU $13,884M, Expenses are 1,826M for a net gain of 12,058m If you want to see more detail on this look at note 3 on page 24. Now for H2 they will have AU $200M from JARE. Total cash will go up a little but no where near 200 M because cash expenses will be greater than cash income, REE prices, and total will decline. Do your own math but my guess it will be about half of what phantom 8 predicts. I guess he just does not get how much useful info is in the AR, SAR, and Q reports so he thinks he can make up better numbers. Since it is a positive post, he did receive 10 up votes so I guess he is not the only one who does not want to use data.
- Forums
- ASX - By Stock
- Ann: Malaysian Operating Licence Update
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

i was just rereading some posts here when i came across this one...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.306B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.86 | $61.13M | 6.800M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 225 | $8.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.91 | 24100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 8.880 |
1 | 80 | 8.850 |
1 | 508 | 8.830 |
1 | 675 | 8.820 |
6 | 3145 | 8.800 |
Price($) | Vol. | No. |
---|---|---|
8.930 | 200 | 1 |
8.950 | 200 | 1 |
8.960 | 650 | 1 |
8.990 | 164 | 1 |
9.020 | 1100 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online